CA-SCIENTIST.COM
Scientist.com, the world’s leading marketplace for biopharma research, today announced the launch of a new large language model (LLM)-powered research assistant called Elisa, named in homage to a widely used research assay and to ELIZA, an early 1960s chatbot. Elisa is the newest addition to a suite of proprietary AI-powered apps created by Scientist.com to improve and accelerate drug research. Marketplace users can now benefit from a powerful, scalable, and intuitive LLM assistant that understands the nuances of pharmaceutical research and has been trained on Scientist.com’s public data sources.
“Elisa is a bridge between advanced technology and our customers, providing them with instant access to marketplace information and a conversational interface that understands their research needs,” said Chris Petersen, Founder and CTO of Scientist.com. “It’s the latest in a series of LLM-powered tools we’ve built to help life science researchers run their drug discovery programs faster and at lower cost.”
Elisa addresses three key challenges for pharma and biotech companies integrating large language models into their operations:
1. It guarantees complete privacy and confidentiality of all data.
2. It provides a cost-efficient solution with the capabilities and flexibility of high-end platforms like Azure or Amazon.
3. It eliminates the need for extensive technical expertise to develop and operate a private LLM on your own infrastructure.
Other LLM-enabled tools on the Scientist.com marketplace help marketplace users negotiate pricing with suppliers, respond quickly to supplier messages, find services and products, and understand legal agreements.
The company also uses machine learning algorithms trained on nearly a decade of marketplace data to create proprietary predictive models that help researchers find and evaluate the best technology and labs for their research needs as well as forecast supplier performance once the research project is initiated. These include the Tumor Model FinderTM, which compares DNA sequencing data on 10,000 oncology models to help researchers identify and purchase the most appropriate model.
To learn more about how Scientist.com is using artificial intelligence across its platform, visit https://scientist.com/ai/ or contact marketing@scientist.com.
About Scientist.com
Scientist.com is the world’s leading AI-enabled marketplace for scientific research. The marketplace simplifies drug discovery research, saving time and money and providing access to the latest innovative tools and technologies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, over 100 biotechnology companies, and the US NIH.
Media contact: For additional information or to schedule an interview with Chris Petersen, please contact Sean at sean@scientist.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240619993515/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Xsolla Strengthens Game Development Opportunities in the UK With Office Hours at Red Bull Gaming Sphere Partnership10.12.2024 10:00:00 CET | Press release
Xsolla Empowers Indie and Mid-Tier Developers with Payment Solutions and Direct-to-Consumer Opportunities Xsolla, a global video game commerce company, is excited to announce its role as the Official Supporting Partner (Payment Solutions) for Office Hours at Red Bull Gaming Sphere’s December 11th event. This collaborative event, hosted at the Red Bull Gaming Sphere in Shoreditch, London, offers a unique combination of co-working spaces, expert panel discussions, and game showcases to foster new opportunities for developers to grow, learn, and expand their reach in the UK and globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241210890933/en/ (Graphic: Xsolla) “We believe in providing equal access to opportunities for everyone and are committed to supporting efforts to help grow the local game development community in the UK,” said Chris Meredith, SVP EMEA at Xsolla. “Through our advanced payment solutions, we aim to em
YANGGUOFU Malatang’s European MALA GALA Debuts in Berlin: Culture as Wings, Fragrance Spreads Worldwide10.12.2024 09:44:00 CET | Press release
The YANGGUOFU Malatang European Spicy Festival, “MALA GALA,” was grandly opened in Berlin on December 5th, accompanied by a comprehensive upgrade of the brand image. With the core concept of “Culture as Wings, Fragrance Spreads Worldwide,” it aims to spread the culture of Eastern cuisine overseas. Since the first store was established in Spain in 2023, YANGGUOFU has quickly opened branches in 10 European countries, winning widespread acclaim. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241206278177/en/ MALA GALA (Photo: Business Wire) The MALA GALA marks the brand’s deep expansion into the European market with the simultaneous opening of new stores in Berlin and Prague. Moving forward, new stores in five countries and ten cities will be linked, and the brand’s sixth-generation stores will officially debut across the European continent, from the UK, France, Germany, and Italy to the Czech Republic. To deepen cultural excha
AQEMIA Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London, UK10.12.2024 09:29:00 CET | Press release
AQEMIA, a pioneering techbio that teaches atomic scale physics to a generative AI to invent innovative medicines, announces two major milestones: $100 million in cumulative funding and the beginning of a global expansion starting with London (United Kingdom). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241210380168/en/ Maximilien Levesque, CEO and Cofounder of AQEMIA (left) and Emmanuelle Martiano Rolland, COO and Cofounder of AQEMIA (Photo: Business Wire) The new $38 million funding round, led by new investor Cathay Innovation, brings total funds raised since inception to over $100 million. This round, coming less than a year after the previous one, follows the successful validation of AQEMIA’s drug discovery platform through outstanding results in internal preclinical programs and pharmaceutical partnerships, particularly in oncology. The funding will support AQEMIA’s development goals, including preparations for clinic
Kioxia Develops OCTRAM (Oxide-Semiconductor Channel Transistor DRAM) Technology10.12.2024 09:22:00 CET | Press release
Kioxia Corporation, a world leader in memory solutions, today announced the development of OCTRAM (Oxide-Semiconductor Channel Transistor DRAM), a new type of 4F2 DRAM, comprised of an oxide-semiconductor transistor that has a high ON current, and an ultra-low OFF current, simultaneously. This technology is expected to realize a low power DRAM by bringing out the ultra-low leakage property of the InGaZnO*1 transistor. This was first announced at the IEEE International Electron Devices Meeting (IEDM) held in San Francisco, CA on December 9, 2024. This achievement was jointly developed by Nanya Technology and Kioxia Corporation. This technology has the potential to lower power consumption in a wide range of applications, including AI and post-5G communication systems, and IoT products. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241209099702/en/ Fig.1: Cross-sectional TEM image for the InGaZnO vertical transistor (Photo: Bu
FINEOS ranked in Top Ten of Everest Group’s Leading 50™ Life & Annuity (L&A) Insurance Technology Providers report10.12.2024 09:00:00 CET | Press release
FINEOS Corporation (ASX:FCL) today announced that Everest Group’s Leading 50TM Life & Annuity (L&A) Insurance Technology Providers report has positioned FINEOS as a leader in the global life, accident and health insurance technology market for 2024. To determine its rankings, Everest Group began with over 200 technology providers serving the broad spectrum of the L&A insurance, retirements, and pensions industry and narrowed the list down based on the assessed company’s revenues, line of business (LoB) coverage, value-chain coverage and client geographic coverage. Ultimately, the renowned research firm arrived at the Leading 50TM Life & Annuity (L&A) Insurance Technology Providers 2024, with FINEOS well-positioned as a result of its scale of operations, scope, technology and innovation, delivery footprint, and buyer satisfaction, in addition to revenue, number of clients and year-over-year growth, all evidenced by previous Everest Group research. Michael Kelly, FINEOS CEO, said, “We ar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom